MD-201

N/A

Report date: 2023/05/17 08:51:34

Base Information

Drug NameMD-201
Drug Alias NameMD-201
ClassificationSmall molecules
Mechanisms of ActionDual specificity protein kinase CLK2 inhibitors
TargetsDual specificity protein kinase CLK2
Therapy Area/IndicationsAlzheimer DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMD Biolab Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMD Biolab Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A